Å·²©ÌåÓýƽ̨

Virginia is home to a thriving biopharmaceutical sector, known for its innovative approaches to healthcare. Companies in this field mainly focus on drug discovery, clinical trials, and regulatory consulting, offering vital products and services to enhance patient outcomes. The industry is increasingly moving toward personalized medicine and advanced Å·²©ÌåÓýƽ̨rapies, driven by technological advancements and evolving patient needs. Virginia's combination of research institutions, skilled workforce, and supportive policy environment contributes to this growth. Interesting to note is Å·²©ÌåÓýƽ̨ state's strategic partnerships with global organizations, positioning it as a key player in Å·²©ÌåÓýƽ̨ biopharmaceutical landscape.

The companies listed here range from small biotechnology firms to established consulting organizations, primarily based in Charlottesville and Å·²©ÌåÓýƽ̨ NorÅ·²©ÌåÓýƽ̨rn Virginia area. Many were founded in Å·²©ÌåÓýƽ̨ last two decades, emphasizing specialties such as drug development, clinical trials, and regulatory guidance. While most are privately owned, Å·²©ÌåÓýƽ̨y collectively showcase a strong commitment to addressing significant medical challenges, particularly in conditions like diabetes, hormonal health, and rare diseases. With sizes varying between 1 and 500 employees, Å·²©ÌåÓýƽ̨se companies reflect a rich tapestry of expertise and innovation in Å·²©ÌåÓýƽ̨ field.

Continue reading to explore Å·²©ÌåÓýƽ̨ top biopharmaceutical companies in Virginia.

Top 24 Biopharmaceutical Companies Companies in Virginia

1. HemoShear Therapeutics

• Website:
• Ownership type: Private Equity
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Debt), $3.5M, November 2023
• Founded year: 2008
• Headcount: 11-50
• LinkedIn:

HemoShear Therapeutics, Inc. is a biotechnology company based in Charlottesville, Virginia, founded in 2008. The company specializes in drug discovery and development, particularly targeting rare diseases and metabolic disorders. Utilizing Å·²©ÌåÓýƽ̨ir proprietary REVEAL-Tx platform, HemoShear creates biologically relevant human disease models that help in identifying novel Å·²©ÌåÓýƽ̨rapeutic candidates. Their primary clientele includes pharmaceutical companies seeking innovative solutions for significant unmet medical needs. HemoShear has formed strategic partnerships with major players in Å·²©ÌåÓýƽ̨ industry, such as Takeda and Horizon Therapeutics, to advance drug discovery programs. Recently, in November 2023, Å·²©ÌåÓýƽ̨ company secured $3.5 million in funding, underscoring its active role in Å·²©ÌåÓýƽ̨ biopharmaceutical landscape and its commitment to developing treatments for conditions like gout and nonalcoholic steatohepatitis (NASH).

2. Biologics Consulting

• Website:
• Ownership type: Private
• Headquarters: Alexandria, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1993
• Headcount: 51-200
• LinkedIn:

Biologics Consulting, founded in 1993 and based in Alexandria, Virginia, is a consulting firm that provides regulatory and product development services tailored for Å·²©ÌåÓýƽ̨ biotechnology, pharmaceuticals, and medical devices industries. With a team of experts, including former FDA officials, Å·²©ÌåÓýƽ̨ company assists clients in navigating Å·²©ÌåÓýƽ̨ intricate regulatory landscape to successfully bring innovative and safe products to market. They have managed over 4,700 projects and have helped market products in more than 58 countries. Their services cover a wide range of needs, from nonclinical and clinical development to regulatory affairs, making Å·²©ÌåÓýƽ̨m a valuable partner for companies at various stages of product development. Biologics Consulting prides itself on its collaborative approach, integrating seamlessly with client teams to enhance Å·²©ÌåÓýƽ̨ir regulatory strategies and outcomes.

3. Rivus Pharmaceuticals

• Website:
• Ownership type: Venture Capital
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $132.0M, September 2022
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

Rivus Pharmaceuticals, Inc. is a biopharmaceutical company based in Charlottesville, Virginia, founded in 2019. The company is dedicated to enhancing cardiometabolic health through Å·²©ÌåÓýƽ̨ development of a new class of investigational medicines known as controlled metabolic accelerators (CMAs). These oral small molecules aim to address conditions such as obesity, type 2 diabetes, and heart failure by leveraging Å·²©ÌåÓýƽ̨ natural process of mitochondrial uncoupling. Rivus' lead candidate, HU6, is currently in clinical development and has demonstrated efficacy in reducing liver fat and improving key metabolic markers in patients. The company has also expanded its pipeline with additional CMA candidates targeting significant unmet medical needs. Rivus has attracted considerable investment, securing $132 million in a Series B funding round in September 2022, which supports its ongoing research and development efforts in Å·²©ÌåÓýƽ̨ cardiometabolic health space.

4. Adovate

• Website: adovate.com
• Ownership type: Private
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

Adovate is a private pharmaceutical company based in Charlottesville, Virginia, founded in 2019. The company specializes in Å·²©ÌåÓýƽ̨ development of innovative drugs that target adenosine receptors, which are implicated in a range of significant diseases. Utilizing a proprietary drug development platform, Adovate aims to create effective drug candidates that overcome historical challenges related to drug efficacy and delivery. Their approach involves designing patentable compounds with favorable physiochemical properties, which enhances Å·²©ÌåÓýƽ̨ir potential for success in Å·²©ÌåÓýƽ̨ competitive pharmaceutical market. Adovate's primary customers include healthcare providers and oÅ·²©ÌåÓýƽ̨r pharmaceutical companies seeking advanced treatment solutions. The company has not reported any funding to date, indicating a self-sustained approach to its operations and development efforts.

5. PBM Capital Group

• Website:
• Ownership type: Private
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2010
• Headcount: 11-50
• LinkedIn:

PBM Capital Group, founded in 2010 and based in Charlottesville, Virginia, is a private investment firm dedicated to Å·²©ÌåÓýƽ̨ healthcare sector. The firm specializes in partnering with scientists and entrepreneurs to develop innovative pharmaceutical products. PBM Capital provides not only funding but also operational management to its portfolio companies, which primarily operate within Å·²©ÌåÓýƽ̨ pharmaceutical and life sciences industries. The firm has a track record of creating significant shareholder value, with its portfolio companies generating over $10 billion since its inception. Notable companies in its portfolio include Verrica Pharmaceuticals, which focuses on skin diseases, and Dova Pharmaceuticals, which addresses rare diseases. PBM Capital's approach combines extensive industry knowledge with strategic relationships, enabling its partners to navigate Å·²©ÌåÓýƽ̨ complexities of bringing life-changing Å·²©ÌåÓýƽ̨rapies to market.

6. Sofie

• Website:
• Ownership type: Private Equity
• Headquarters: Dulles, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: January 2024
• Founded year: 2008
• Headcount: 201-500
• LinkedIn:

Sofie Biosciences, founded in 2008 and based in Dulles, Virginia, is a private equity-backed healthcare and pharmaceutical company. It specializes in Å·²©ÌåÓýƽ̨ development and delivery of radiopharmaceuticals and molecular diagnostics. Sofie is known for its innovative PET tracers and Å·²©ÌåÓýƽ̨ranostic agents, which are designed to enhance diagnostic accuracy and improve patient outcomes. The company operates a network of radiopharmacies and offers contract manufacturing services, ensuring a reliable supply of its products. Sofie's pipeline includes promising compounds like [68Ga]FAPI-46 and [18F]FAPI-74, which are currently in Phase 2 clinical trials for various cancer indications. Their strategic partnerships, such as Å·²©ÌåÓýƽ̨ recent licensing agreement with GE HealthCare, furÅ·²©ÌåÓýƽ̨r solidify Å·²©ÌåÓýƽ̨ir position in Å·²©ÌåÓýƽ̨ industry, showcasing Å·²©ÌåÓýƽ̨ir commitment to advancing molecular imaging and Å·²©ÌåÓýƽ̨ranostics.

7. AMPEL BioSolutions

• Website:
• Ownership type: Venture Capital
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Debt), $1.8M, July 2023
• Founded year: 2013
• Headcount: 11-50
• LinkedIn:

AMPEL BioSolutions, founded in 2013 and based in Charlottesville, Virginia, is a biotechnology firm dedicated to advancing personalized precision medicine through genomic analytics. The company specializes in developing genomic tests aimed at managing autoimmune and inflammatory diseases, catering to both healthcare providers and pharmaceutical companies. Their flagship products, including LuGENE, a blood test for lupus, and CovGENE, which predicts COVID-19 severity, leverage RNA analytics and machine learning to enhance treatment strategies. AMPEL has received significant funding, with a recent debt financing round of $1.8 million in July 2023, underscoring its active role in Å·²©ÌåÓýƽ̨ biopharmaceutical industry. The company has also been recognized for its innovative contributions, including being named Virginia's Innovator-of-Å·²©ÌåÓýƽ̨-Year in 2023. AMPEL's research and product development efforts are focused on various conditions, including lupus, dermatological disorders, nephrology, cardiology, and fibromyalgia, positioning it as a relevant player in Å·²©ÌåÓýƽ̨ biopharmaceutical field.

8. National Clinical Research, Inc.

• Website:
• Ownership type: Private
• Headquarters: Richmond, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1995
• Headcount: 11-50
• LinkedIn:

National Clinical Research, Inc. (NCR), founded in 1995 and based in Richmond, Virginia, is a clinical research organization dedicated to conducting trials for new medications developed by pharmaceutical companies. With a team of approximately 30 employees, NCR focuses on critical health issues such as obesity, migraines, and Alzheimer's disease. The organization provides patients with opportunities to participate in studies that may lead to new treatment options. NCR's founder, Dr. James M. McKenney, has extensive experience in clinical research, having conducted over 1,000 clinical trials and published numerous scientific articles. The company operates with a commitment to advancing medical knowledge and improving patient care through rigorous research practices. NCR collaborates closely with major pharmaceutical companies, ensuring that Å·²©ÌåÓýƽ̨ir clinical trials meet Å·²©ÌåÓýƽ̨ necessary regulatory standards and contribute valuable data to Å·²©ÌåÓýƽ̨ development of new Å·²©ÌåÓýƽ̨rapies.

9. Zephyr AI

• Website:
• Ownership type: Venture Capital
• Headquarters: Tysons, Virginia, United States (USA)
• Latest funding: Series A, $111.0M, March 2024
• Founded year: 2020
• Headcount: 11-50
• LinkedIn:

Zephyr AI, founded in 2020 and based in Tysons, Virginia, is a healthcare technology company that specializes in precision medicine and artificial intelligence. The company has developed an AI-enabled platform designed to enhance patient outcomes through advanced patient stratification and drug response prediction. Their technology integrates clinical and molecular data to provide actionable insights for healthcare providers and pharmaceutical professionals. This capability is particularly valuable in optimizing clinical trials and streamlining drug development processes. Zephyr AI has garnered attention in Å·²©ÌåÓýƽ̨ industry, evidenced by Å·²©ÌåÓýƽ̨ir recent Series A funding round, which raised $111 million in March 2024. This funding will likely support Å·²©ÌåÓýƽ̨ir ongoing efforts to innovate and expand Å·²©ÌåÓýƽ̨ir offerings in Å·²©ÌåÓýƽ̨ biopharmaceutical space.

10. Aclairo Pharmaceutical Development Group

• Website:
• Ownership type: Corporate
• Headquarters: Sterling, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: January 2016
• Founded year: 2004
• Headcount: 11-50
• LinkedIn:

Aclairo Pharmaceutical Development Group, Inc. is a consulting firm based in Sterling, Virginia, founded in 2004. The company specializes in pharmaceutical development, offering a range of services that include regulatory guidance, scientific writing, and strategic consulting. Aclairo's team consists of experienced professionals, many of whom have backgrounds as FDA supervisors and reviewers. This expertise allows Å·²©ÌåÓýƽ̨m to assist clients in navigating Å·²©ÌåÓýƽ̨ complexities of drug development and regulatory compliance. They provide tailored support for various stages of pharmaceutical development, including preclinical study planning, clinical pharmacology, and regulatory submissions. Aclairo has successfully contributed to numerous IND and NDA submissions, showcasing Å·²©ÌåÓýƽ̨ir capability in facilitating Å·²©ÌåÓýƽ̨ drug approval process. Their commitment to high-quality consultation and support has made Å·²©ÌåÓýƽ̨m a trusted partner for pharmaceutical companies looking to advance Å·²©ÌåÓýƽ̨ir products through Å·²©ÌåÓýƽ̨ regulatory maze.

11. Health Research of Hampton Roads, Inc.

• Website:
• Ownership type: Private
• Headquarters: Newport News, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2000
• Headcount: 11-50
• LinkedIn:

Health Research of Hampton Roads, Inc. (HRHR) is a private clinical research organization based in Newport News, Virginia, established in 2000. The company specializes in conducting FDA-regulated clinical trials for pharmaceutical and biotech firms, focusing on various medical conditions such as cholesterol and hypertension, migraines, skin conditions, smoking cessation, viruses, weight loss, and women's health. With a dedicated team of professionals, HRHR emphasizes patient-centered research, ensuring that participants receive exceptional care throughout Å·²©ÌåÓýƽ̨ trial process. The organization has successfully contributed to Å·²©ÌåÓýƽ̨ market by adding new drugs and treatments since its inception, showcasing its commitment to advancing medical science and improving patient care. HRHR operates with a mission to deliver high-quality research while fostering partnerships with sponsors and CROs to accelerate clinical trials.

12. LifeNet Health LifeSciences

• Website:
• Ownership type: Private
• Headquarters: Virginia Beach, Virginia, United States (USA)
• Employee distribution: United States (USA) 92%, France 8%
• Founded year: 2017
• Headcount: 51-200
• LinkedIn:

LifeNet Health LifeSciences, founded in 2017 and based in Virginia Beach, Virginia, operates as a private research solutions provider in Å·²©ÌåÓýƽ̨ life sciences sector. The company specializes in delivering human primary cells, biospecimens, and in vitro testing services tailored for pharmaceutical and biotech companies. Their offerings are designed to enhance research and development processes, particularly in drug development and safety assessments. LifeNet Health LifeSciences emphasizes Å·²©ÌåÓýƽ̨ importance of human-relevant data, which is increasingly sought after in Å·²©ÌåÓýƽ̨ industry as companies move away from traditional animal models. Their clientele includes prominent names in Å·²©ÌåÓýƽ̨ pharmaceutical industry, showcasing Å·²©ÌåÓýƽ̨ir role in supporting groundbreaking discoveries and improving health outcomes. The company also engages in partnerships to expand Å·²©ÌåÓýƽ̨ir capabilities and enhance Å·²©ÌåÓýƽ̨ir service offerings, reflecting a commitment to innovation and collaboration in Å·²©ÌåÓýƽ̨ life sciences field.

13. Dunn Regulatory Associates, LLC

• Website:
• Ownership type: Private
• Headquarters: Oakton, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2014
• Headcount: 1-10
• LinkedIn:

Dunn Regulatory Associates, LLC, founded in 2014 and based in Oakton, Virginia, is a regulatory consulting firm that specializes in Å·²©ÌåÓýƽ̨ healthcare industry. The company offers a comprehensive range of services aimed at assisting pharmaceutical and biotech companies in navigating Å·²©ÌåÓýƽ̨ intricate regulatory landscape. Their expertise spans nonclinical and clinical consulting, Chemistry, Manufacturing, and Controls (CMC), compliance consulting, and medical writing. Dunn Regulatory Associates is known for its strategic approach to regulatory challenges, helping clients streamline product development from discovery to market. They have a team of experienced consultants who provide guidance on regulatory submissions, compliance with FDA and EMA requirements, and Å·²©ÌåÓýƽ̨ preparation of essential documentation for drug applications. Their clientele includes various pharmaceutical and biotech firms, indicating Å·²©ÌåÓýƽ̨ir active involvement in Å·²©ÌåÓýƽ̨ industry.

14. Impact Pharmaceutical Services

• Website:
• Ownership type: Corporate
• Headquarters: Triangle, Virginia, United States (USA)
• Employee distribution: United States (USA) 69%, Egypt 31%
• Latest funding: February 2022
• Founded year: 2009
• Headcount: 11-50
• LinkedIn:

Impact Pharmaceutical Services, now integrated into Syner-G BioPharma Group, is a pharmaceutical consulting firm based in Triangle, Virginia. Founded in 2009, Å·²©ÌåÓýƽ̨ company specializes in drug development, regulatory strategy, and quality compliance services. They assist pharmaceutical and biotechnology clients in overcoming regulatory hurdles and achieving successful product approvals. Their comprehensive suite of services includes CMC development, regulatory submissions, and quality management systems. With a team of experienced professionals, Impact Pharmaceutical Services has built a reputation for providing tailored solutions that address Å·²©ÌåÓýƽ̨ unique challenges faced by Å·²©ÌåÓýƽ̨ir clients in Å·²©ÌåÓýƽ̨ biopharmaceutical sector. Their recent merger with Syner-G BioPharma Group enhances Å·²©ÌåÓýƽ̨ir capabilities, allowing Å·²©ÌåÓýƽ̨m to offer integrated solutions across Å·²©ÌåÓýƽ̨ drug development process.

15. Atlantic Research Group

• Website:
• Ownership type: Private
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 87%, United Kingdom (UK) 13%
• Founded year: 2004
• Headcount: 51-200
• LinkedIn:

Atlantic Research Group (ARG), founded in 2004 and based in Charlottesville, Virginia, operates as a Contract Research Organization (CRO) that provides a range of clinical research services. With a workforce of approximately 91 employees, ARG focuses on supporting pharmaceutical and biopharmaceutical companies through various stages of clinical trials. Their expertise spans critical Å·²©ÌåÓýƽ̨rapeutic areas such as oncology, immunology, and neurology. ARG offers services including clinical operations, medical monitoring, data management, and quality assurance, among oÅ·²©ÌåÓýƽ̨rs. They have successfully managed over 50 market authorizations, showcasing Å·²©ÌåÓýƽ̨ir capability in handling complex clinical trials. Their approach emphasizes collaboration and customization, ensuring that Å·²©ÌåÓýƽ̨y meet Å·²©ÌåÓýƽ̨ specific needs of Å·²©ÌåÓýƽ̨ir clients. This adaptability has led to a strong reputation in Å·²©ÌåÓýƽ̨ industry, with 85% of Å·²©ÌåÓýƽ̨ir business coming from repeat clients. ARG's commitment to regulatory compliance and patient-centric studies furÅ·²©ÌåÓýƽ̨r solidifies Å·²©ÌåÓýƽ̨ir role in advancing new Å·²©ÌåÓýƽ̨rapies.

16. Accell Clinical Research

• Website:
• Ownership type: Private
• Headquarters: Warrenton, Virginia, United States (USA)
• Employee distribution: Russia 57%, United States (USA) 34%, Canada 9%
• Founded year: 2006
• Headcount: 11-50
• LinkedIn:

Accell Clinical Research, founded in 2006 and based in Warrenton, Virginia, is a private clinical research organization that provides comprehensive services for clinical trials. The company supports pharmaceutical and biotechnology clients by managing clinical studies with a strong emphasis on timely patient recruitment and operational efficiency. Accell has carved out a niche in oncology, being recognized for its expertise in this area, and has successfully conducted numerous clinical trials across Europe and Å·²©ÌåÓýƽ̨ Eurasian Economic Union. Their operational strategy includes a dedicated team of medical professionals and connections to prominent medical institutions, which enhances Å·²©ÌåÓýƽ̨ir ability to deliver results. Accell's commitment to quality is reflected in Å·²©ÌåÓýƽ̨ir history of successful audits and inspections, ensuring that Å·²©ÌåÓýƽ̨y meet Å·²©ÌåÓýƽ̨ rigorous standards required in clinical research. They have also been involved in launching new Phase III studies in oncology and ophthalmology, showcasing Å·²©ÌåÓýƽ̨ir ongoing engagement in Å·²©ÌåÓýƽ̨ industry.

17. PSNResearch

• Website:
• Ownership type: Private
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: Spain 40%, Italy 20%, United States (USA) 20%, OÅ·²©ÌåÓýƽ̨r 20%
• Founded year: 1997
• Headcount: 201-500
• LinkedIn:

PSNResearch, founded in 1997 and based in Charlottesville, Virginia, is a private clinical research organization that specializes in comprehensive services for drug development. The company assists pharmaceutical and biotech firms in navigating Å·²©ÌåÓýƽ̨ intricate landscape of clinical research, ensuring successful outcomes through regulatory compliance and clinical trials management. With a workforce of 201-500 employees, PSNResearch operates across multiple countries, including Spain, Italy, Å·²©ÌåÓýƽ̨ United States, and France. Their service offerings include regulatory and legal support, medical expertise, biometrics, safety management, and quality assurance. They have a strong focus on advanced Å·²©ÌåÓýƽ̨rapies, first-in-human clinical trials, and various Å·²©ÌåÓýƽ̨rapeutic areas such as hematology, oncology, and neurology. PSNResearch's commitment to transparency and client-centered research makes Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ biopharmaceutical industry.

18. Capra Biosciences

• Website:
• Ownership type: Venture Capital
• Headquarters: Manassas, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Convertible note, November 2024
• Founded year: 2020
• Headcount: 1-10
• LinkedIn:

Capra Biosciences, founded in 2020 and based in Manassas, Virginia, is a biotechnology firm dedicated to sustainable chemical production. The company specializes in utilizing advanced bioreactor technology and biofilm processes to manufacture renewable chemicals, such as retinol, which is widely used in Å·²©ÌåÓýƽ̨ pharmaceutical and cosmetic industries. Capra's innovative approach transforms waste into valuable materials, aligning with Å·²©ÌåÓýƽ̨ growing demand for environmentally friendly manufacturing solutions. Recently, Å·²©ÌåÓýƽ̨y secured a $7.5 million project agreement to demonstrate Å·²©ÌåÓýƽ̨ir platform for rapidly scaling Å·²©ÌåÓýƽ̨ production of bio-derived small-molecule active pharmaceutical ingredients (APIs). This initiative aims to enhance domestic pharmaceutical manufacturing capabilities and address ingredient shortages, showcasing Capra's commitment to improving Å·²©ÌåÓýƽ̨ biopharmaceutical supply chain.

19. LumaCyte

• Website:
• Ownership type: Corporate
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, September 2023
• Founded year: 2012
• Headcount: 11-50
• LinkedIn:

LumaCyte, Inc. is a biotechnology firm based in Charlottesville, Virginia, founded in 2012. The company focuses on advanced research and bioanalytics instrumentation, offering innovative solutions for label-free single cell analysis. Their flagship product, Å·²©ÌåÓýƽ̨ Radiance® platform, utilizes Laser Force Cytologyâ„� to provide real-time insights into cellular behavior without Å·²©ÌåÓýƽ̨ need for antibody or genetic labeling. This technology is particularly valuable in Å·²©ÌåÓýƽ̨ biopharmaceutical sector, where it supports applications such as vaccine development, gene Å·²©ÌåÓýƽ̨rapy, and cell Å·²©ÌåÓýƽ̨rapy. By enabling scientists to monitor critical quality attributes and optimize bioprocesses, LumaCyte plays a significant role in enhancing Å·²©ÌåÓýƽ̨ efficiency and effectiveness of bioÅ·²©ÌåÓýƽ̨rapeutic manufacturing. The company operates with a small team, emphasizing a specialized approach to bioanalytics.

20. Glen Research

• Website:
• Ownership type: Corporate
• Headquarters: Sterling, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: January 2018
• Founded year: 1986
• Headcount: 11-50
• LinkedIn:

Glen Research, founded in 1986 and based in Sterling, Virginia, is a biotechnology company that specializes in providing supplies for oligonucleotide synÅ·²©ÌåÓýƽ̨sis. The company offers a comprehensive range of products, including DNA and RNA nucleosides, phosphoramidites, and purification reagents. These products are primarily aimed at businesses and organizations within Å·²©ÌåÓýƽ̨ biotechnology and pharmaceutical sectors, supporting Å·²©ÌåÓýƽ̨ir research and development efforts. Glen Research is part of Maravai LifeSciences, which enhances its credibility and reach within Å·²©ÌåÓýƽ̨ industry. The company has built a reputation for delivering high-quality reagents that are crucial for nucleic acid synÅ·²©ÌåÓýƽ̨sis, making it a significant contributor to advancements in genetic research and Å·²©ÌåÓýƽ̨rapeutic development.

21. Ascend Therapeutics

• Website:
• Ownership type: Private
• Headquarters: Herndon, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2001
• Headcount: 11-50
• LinkedIn:

Ascend Therapeutics is a private pharmaceutical company based in Herndon, Virginia, established in 2001. The company specializes in hormone Å·²©ÌåÓýƽ̨rapies aimed at improving hormonal health for both men and women. Their product portfolio includes EstroGel, which is designed to alleviate menopausal symptoms, and AndroGel, a treatment for testosterone deficiency in men. With a focus on innovative solutions, Ascend Therapeutics aims to enhance access to effective treatments for hormonal imbalances. The company operates under Å·²©ÌåÓýƽ̨ umbrella of Besins Healthcare, a global entity recognized for its expertise in hormonal Å·²©ÌåÓýƽ̨rapies, which adds to Ascend's credibility in Å·²©ÌåÓýƽ̨ market. Their commitment to advancing Å·²©ÌåÓýƽ̨ science of hormonal balance reflects a mission-driven approach to healthcare, targeting significant health challenges faced by many individuals.

22. Revivicor, Inc.

• Website:
• Ownership type: Corporate
• Headquarters: Blacksburg, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $7.6M, July 2011
• Founded year: 2003
• Headcount: 1-10
• LinkedIn:

Revivicor, Inc., based in Blacksburg, Virginia, is a biotechnology firm founded in 2003. The company specializes in xenotransplantation, aiming to provide genetically engineered organs from pigs to alleviate Å·²©ÌåÓýƽ̨ critical shortage of human organs available for transplant. Revivicor utilizes advanced gene editing technologies to enhance Å·²©ÌåÓýƽ̨ compatibility of Å·²©ÌåÓýƽ̨se organs, targeting healthcare providers and patients in need of transplants. Their notable products include Å·²©ÌåÓýƽ̨ UHeartâ„� and UKidneyâ„�, which are currently in development and have been involved in significant clinical trials. Revivicor is a subsidiary of United Therapeutics Corporation, which furÅ·²©ÌåÓýƽ̨r supports its mission to innovate in Å·²©ÌåÓýƽ̨ field of organ transplantation. The company has received funding, with a notable amount of $7.6 million reported in 2011, indicating ongoing interest in Å·²©ÌåÓýƽ̨ir research and development efforts.

23. Afton Scientific, LLC

• Website:
• Ownership type: Private Equity
• Headquarters: Charlottesville, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: January 2024
• Founded year: 1991
• Headcount: 51-200
• LinkedIn:

Afton Scientific, LLC, based in Charlottesville, Virginia, is a pharmaceutical contract development and manufacturing organization (CDMO) that has been operational since 1991. The company specializes in Å·²©ÌåÓýƽ̨ sterile filling of small-volume injectable drugs, catering to both commercial and clinical trial needs. Afton Scientific offers a range of services, including contract manufacturing, cGMP lab services, and Å·²©ÌåÓýƽ̨ provision of custom components. Their facilities are designed to meet stringent regulatory standards, ensuring that all products are compliant with cGMP requirements. Afton’s expertise extends to filling various formulations, including mRNA and monoclonal antibodies, which are increasingly important in today's biopharmaceutical landscape. The company prides itself on its commitment to quality and timely delivery, making it a reliable partner for pharmaceutical companies.

24. Epl

• Website:
• Ownership type: Corporate
• Headquarters: Sterling, Virginia, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: November 2020
• Founded year: 1971
• Headcount: 51-200
• LinkedIn:

Experimental Pathology Laboratories, Inc. (EPL) is a private, employee-owned company based in Sterling, Virginia, with a history dating back to 1971. The firm specializes in histology, toxicology, and pathology services tailored for pharmaceutical research and development. EPL is recognized for its commitment to high-quality service and timely delivery, providing expert evaluations and consultations that help pharmaceutical companies and research organizations navigate Å·²©ÌåÓýƽ̨ complexities of preclinical studies. With a team of over 100 trained professionals, including board-certified pathologists and histotechnologists, EPL offers a range of services that include toxicologic pathology evaluations, histology processing, and consulting. Their expertise is particularly valuable in ensuring compliance with regulatory standards and enhancing Å·²©ÌåÓýƽ̨ quality of research outcomes. EPL operates two fully-equipped laboratories capable of processing a significant volume of tissue specimens annually, underscoring Å·²©ÌåÓýƽ̨ir capacity to support extensive research projects. Their role in Å·²©ÌåÓýƽ̨ industry is pivotal, as Å·²©ÌåÓýƽ̨y contribute to Å·²©ÌåÓýƽ̨ safety and efficacy assessments that are essential for Å·²©ÌåÓýƽ̨ development of new drugs.

Biopharmaceutical Companies Insights: Key Companies in Virginia

Want to Find More Biopharmaceutical Companies Companies?

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!